Both in Pharmaceuticals
PepGen vs ALX Oncology Holdings
Over the past year PEPG returned −47.9% and ALXO returned −21.3%; their daily moves had a correlation of 0.15.
PEPG −47.9% ALXO −21.3%Growth of $1, one year, split-adjusted
| Metric | PEPG | ALXO |
|---|---|---|
| Price | $2.36 | $1.22 |
| Market cap | $163.5M | $168.7M |
| Today | −2.07% | 0.00% |
| 1 month | +6.8% | −6.2% |
| 6 months | +34.9% | −27.8% |
| Year to date | −63.7% | +8.0% |
| 1 year | −47.7% | −23.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $117.2M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 76.4% | 88.9% |
| Short % of float | 9.6% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).